CbdMD Analyst Ratings
CbdMD Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2023 | 210.24% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 06/18/2021 | 236.09% | Cantor Fitzgerald | $4.1 → $3.25 | Reinstates | → Neutral |
| 02/03/2021 | 323.99% | Cantor Fitzgerald | $4.3 → $4.1 | Reiterates | → Neutral |
| 01/29/2021 | 344.67% | Cantor Fitzgerald | $3.6 → $4.3 | Maintains | Neutral |
| 09/09/2020 | 313.65% | Benchmark | $3 → $4 | Maintains | Speculative Buy |
| 08/13/2020 | 272.29% | Cantor Fitzgerald | $1.8 → $3.6 | Maintains | Neutral |
| 05/18/2020 | 86.14% | Cantor Fitzgerald | $1.2 → $1.8 | Maintains | Neutral |
| 12/19/2019 | 623.89% | Benchmark | $9 → $7 | Maintains | Speculative Buy |
| 11/08/2019 | 251.6% | Cantor Fitzgerald | → $3.4 | Initiates Coverage On | → Neutral |
| 09/10/2019 | 830.71% | Benchmark | → $9 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/05/2023 | 210.24% | Maxim集团 | →$3 | 开始承保 | →购买 |
| 06/18/2021 | 236.09% | 康托·菲茨杰拉德 | $4.1→$3.25 | 恢复 | →中性 |
| 02/03/2021 | 323.99% | 康托·菲茨杰拉德 | $4.3→$4.1 | 重申 | →中性 |
| 2021/01/29 | 344.67% | 康托·菲茨杰拉德 | $3.6→$4.3 | 维护 | 中性 |
| 09/09/2020 | 313.65% | 基准 | $3→$4 | 维护 | 投机性购买 |
| 2020年08月13日 | 272.29% | 康托·菲茨杰拉德 | $1.8→$3.6 | 维护 | 中性 |
| 05/18/2020 | 86.14% | 康托·菲茨杰拉德 | $1.2→$1.8 | 维护 | 中性 |
| 2019年12月19日 | 623.89% | 基准 | $9→$7 | 维护 | 投机性购买 |
| 2019年8月11日 | 251.6% | 康托·菲茨杰拉德 | →$3.4 | 开始承保 | →中性 |
| 2019年09月10日 | 830.71% | 基准 | →$9 | 开始承保 | →投机性买入 |
What is the target price for cbdMD (YCBD)?
CbdMD(YCBD)的目标价是多少？
The latest price target for cbdMD (AMEX: YCBD) was reported by Maxim Group on October 5, 2023. The analyst firm set a price target for $3.00 expecting YCBD to rise to within 12 months (a possible 210.24% upside). 1 analyst firms have reported ratings in the last year.
Maxim Group于2023年10月5日报道了cbdMD(美国证券交易所代码：YCBD)的最新目标价。这家分析公司将目标价定为3美元，预计YCBD将在12个月内上涨至(可能上涨210.24%)。1家分析公司在过去一年公布了评级。
What is the most recent analyst rating for cbdMD (YCBD)?
CbdMD(YCBD)的最新分析师评级是多少？
The latest analyst rating for cbdMD (AMEX: YCBD) was provided by Maxim Group, and cbdMD initiated their buy rating.
Maxim Group提供了对cbdMD(美国证券交易所代码：YCBD)的最新分析师评级，cbdMD启动了他们的买入评级。
When is the next analyst rating going to be posted or updated for cbdMD (YCBD)?
CbdMD(YCBD)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of cbdMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for cbdMD was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与cbdMD的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。CbdMD的上一次评级是在2023年10月5日提交的，因此您应该预计下一次评级将在2024年10月5日左右提供。
Is the Analyst Rating cbdMD (YCBD) correct?
分析师对cbdMD(YCBD)的评级正确吗？
While ratings are subjective and will change, the latest cbdMD (YCBD) rating was a initiated with a price target of $0.00 to $3.00. The current price cbdMD (YCBD) is trading at is $0.97, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的cbdMD(YCBD)评级是以0.00美元至3.00美元的目标价启动的。目前cbdMD(YCBD)的交易价格为0.97美元，在分析师的预测区间内。